SCHEMBL1176644

SCHEMBL1176644

[CH2]C(=O)Nc1cc(Cl)c2ccccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESRRA P11474 2/20 0.41
RAB9A P51151 6/20 0.39
MEN1 O00255 6/20 0.39
KMT2A Q03164 6/20 0.39
NPC1 O15118 5/20 0.39
KDM4E B2RXH2 5/20 0.39
MAPT P10636 5/20 0.39
GAA P10253 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
TRPV1 Q8NER1 1/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2A6 P11509 1/20 0.38
SERPINE1 P05121 1/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 3/20 0.38
APAF1 O14727 2/20 0.38
CDC25B P30305 2/20 0.38
CASP3 P42574 2/20 0.38
SENP8 Q96LD8 2/20 0.38
SENP7 Q9BQF6 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1176646 0.83 ESRRA (0.57) ESRRARAB9AMEN1KMT2ANPC1
SCHEMBL1176794 0.76 ALDH1A1 (0.41) ESRRAMEN1KMT2AKDM4EGAA
SCHEMBL1176632 0.73 RAB9A (0.65) RAB9AMEN1KMT2ANPC1KDM4E
SCHEMBL27919270 0.73 CYP2A6 (0.45) ESRRAKDM4EMAPTTDP1CYP1A2
SCHEMBL1176869 0.72 ALDH1A1 (0.45) ESRRAMEN1KMT2AKDM4EMAPT
SCHEMBL1176865 0.72 CYP2A6 (0.41) ESRRAMEN1KMT2AKDM4EMAPT
SCHEMBL1177179 0.72 MAOA (0.45) RAB9AMEN1KMT2ANPC1KDM4E
SCHEMBL11688186 0.70 KMT2A (0.46) RAB9AMEN1KMT2ANPC1KDM4E
SCHEMBL1176619 0.69 CYP1A2 (0.60) RAB9AMEN1KMT2ANPC1KDM4E
SCHEMBL7840769 0.68 MEN1 (0.52) MEN1KMT2AKDM4EMAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110045397-A1 CHARGE CONTROL AGENT AND RELATED ART KURODA KAZUYOSHI 2011-02-24 US disclosed
US-20090053641-A1 CHARGE CONTROL AGENT AND RELATED ART ORIENT CHEMICAL INDUSTRIES, LTD. (JP) 2009-02-26 US disclosed
EP-1862860-A1 CHARGE CONTROL AGENT AND RELATED TECHNIQUE Orient Chemical Industries, Ltd. (JP) 2007-12-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090053641-A1 CHARGE CONTROL AGENT AND RELATED ART H1-4, CECR2, DOT1L ESRRA 1375/4885RAB9A 781/4885MEN1 4536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.